Bristol-Myers Squibb: Number of Employees 2006-2019 | BMY

Interactive chart of Bristol-Myers Squibb (BMY) annual worldwide employee count from 2006 to 2019.
  • Bristol-Myers Squibb total number of employees in 2019 was 30,000, a 28.76% increase from 2018.
  • Bristol-Myers Squibb total number of employees in 2018 was 23,300, a 1.69% decline from 2017.
  • Bristol-Myers Squibb total number of employees in 2017 was 23,700, a 5.2% decline from 2016.
  • Bristol-Myers Squibb total number of employees in 2016 was 25,000, a 0% decline from 2015.
Bristol-Myers Squibb Annual Number of Employees
2019 30,000
2018 23,300
2017 23,700
2016 25,000
2015 25,000
2014 25,000
2013 28,000
2012 28,000
2011 27,000
2010 27,000
2009 28,000
2008 35,000
2007 42,000
2006 43,000
2005 43,000
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $125.834B $26.145B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $345.705B 15.11
Roche Holding AG (RHHBY) Switzerland $277.843B 0.00
Merck (MRK) United States $195.141B 14.82
Novartis AG (NVS) Switzerland $188.959B 15.73
Pfizer (PFE) United States $181.075B 11.06
Novo Nordisk (NVO) Denmark $142.554B 24.47
Eli Lilly (LLY) United States $132.760B 22.97
AstraZeneca (AZN) United Kingdom $117.205B 25.23
AbbVie (ABBV) United States $112.508B 8.52
Sanofi (SNY) France $109.481B 13.01
GlaxoSmithKline (GSK) United Kingdom $94.546B 11.99
Bayer (BAYRY) Germany $53.976B 7.78
H Lundbeck (HLUYY) Denmark $5.923B 10.29
Innoviva (INVA) United States $1.191B 8.22